TTX-030

· Trishula Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TTX-030, covering 2024-12-04 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers [Phase 1]